close

Enter

Log in using OpenID

Apixaban Market

embed
Increasing prevalence of venous thromboembolism related conditions is expected to aid in growth of the apixaban market. For instance, according to International Society on Thrombosis and Haemostasis 2014 facts, revealed that around 10 million cases
Apixaban Market INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND
OPPORTUNITY ANALYSIS, 2016–2024
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Apixaban Market : Overview
Increasing prevalence of venous thromboembolism related conditions is expected to
aid in growth of the apixaban market. For instance, according to International
Society on Thrombosis and Haemostasis 2014 facts, revealed that around 10 million
cases of venous thromboembolism occur annually across low, middle and high
income countries. Moreover, increasing therapeutic indications for apixaban is
expected to boost the apixaban market growth. For instance, in 2014, the U.S. Food
and Drug Administration approved Eliquis for the treatment of deep vein
thrombosis (DVT) prophylaxis and pulmonary embolism (PE) and also for the
reduction in risk of recurrent PE and DVT following initial therapy. Furthermore,
government and private organizations are significantly investing capital in
healthcare research and development and this is also likely to propel growth of the
Apixaban market. However, adverse effects of apixaban such as increased risk of
thrombotic events after premature discontinuation and bleeding is expected to
hamper adoption of this. This in turn is expected to adversely affect growth of the
market. According to a study published in the Current Medical Research and
Opinion 2017 stated about the bleeding risk associated with use of apixaban.
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Apixaban Market : Taxonomy
On the basis of dosage form:
•
Capsule
•
Tablet
On the basis of distribution channel:
•
Hospitals
•
Clinics
•
Retail Pharmacies
•
Online Pharmacies
On the basis of geography:
•
North America
•
Latin America
Request A Sample [email protected]
https://www.coherentmarketinsights.com/insight/request-sample/1898
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Apixaban Market : Key Players
●
●
●
●
●
●
●
●
●
Bristol-Myers Squibb
Portola Pharmaceuticals
C. H. Boehringer Sohn
Pfizer
Roche
CoaguSense
Siemens
Alere
Abbott.
Get More [email protected]
https://www.coherentmarketinsights.com/ongoing-insight/apixaban-market-1898
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting
organization focused on assisting its plethora of clients achieve transformational
growth by helping them make critical business decisions. We are headquartered in
India, with an office at the global financial capital in the U.S. Our client base
includes players from across all business verticals in over 150 countries worldwide.
We are uniquely positioned to help businesses around the globe deliver practical
and lasting results through various recommendations about operational
improvements, technologies, emerging market trends and new working methods.
We offer both customized and syndicated market research reports that help our
clients create visionary growth plans to provide traction to their business. We
meticulously study emerging trends across various industries at both the global and
regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
MARKET INTELLIGENCE
SERVICES
© Coherent market Insights. All Rights Reserved
CUSTOMIZED
RESEARCH
CONSULT STUDIES
SYNDICATED RESEARCH
COUNTRY SPECIFIC
STUDIES
ABOUT CMI
SECTOR
COVERAGE
BIOTECHNOLOGY
CLINICAL
DIAGNOSTIC
MEDICAL DEVICES
MEDICAL
IMAGING
OUR CLIENTS








Global Leading Equipment and System Manufacturers
Component Providers and System Integrators
Distributors, Retailors and Value Added Resellers
Healthcare IT Solutions Developers
Marketing Consultancies and the Advertising Industry
Private and Government organization
Outsourcing Companies
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
HEALTHCARE IT
PHARMACEUTICAL
ABOUT COHERENT MARKET INSIGHTS
KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per
Year
150+
Consulting Projects Till Date
125+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEAR
CH
EXCEL
FORECAST
DATABASE
COMPETITIVE
ASSESSMENT
Clients Worldwide Per Year
110+
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including
chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely
designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed
markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
© Coherent market Insights. All Rights Reserved
THANK YOU
To know more about us, visit our website:
www.coherentmarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact:
Mr. Shah
(Manager - Business Development)
Coherent Market Insights
[email protected]
+1-206-701-6702
© Coherent market Insights. All Rights Reserved
Author
sujit Pawar
sujit Pawar20   documents Email
Document
Category
Health and Medicine
Views
4
File Size
440 KB
Tags
Apixaban Market, apixaban
1/--pages
Report inappropriate content